{
}
President-elect Donald Trump has appointed Robert F. Kennedy Jr. as the head of the Department of Health and Human Services, a decision that positions a well-known vaccine skeptic in a key federal health role. Trump emphasized the importance of protecting Americans from harmful substances, including chemicals and pharmaceuticals, which he claims contribute to the nation's health crisis. Following the announcement, vaccine stocks experienced a decline.
Merck & Co. has entered into a deal with LaNova Medicines Ltd. to license an experimental cancer antibody, LM-299, for $588 million upfront, with potential milestone payments reaching up to $2.7 billion. This agreement enhances Merck's focus on dual-targeted antibodies, providing exclusive global rights to the bispecific antibody that targets cancer through multiple mechanisms.
Merck & Co. has acquired worldwide rights to LaNova Medicines' cancer therapy LM-299 for $588 million, a bispecific immunotherapy targeting PD-1 and VEGF, currently in Phase 1 testing. This move comes as a response to increasing competition, particularly after ivonescimab outperformed Keytruda in a lung cancer trial. The deal could yield LaNova up to $2.7 billion based on development milestones, highlighting Merck's strategy to bolster its pipeline ahead of Keytruda's patent expiration in 2028.
The global healthcare services market is projected to grow from $8,348.44 billion in 2023 to $8,963.64 billion in 2024, driven by advancements in medical technology, an aging population, and health insurance expansion. By 2028, it is expected to reach $10,908.99 billion, with key trends including telemedicine integration and patient-centered care. Shared medical appointments are gaining traction as a cost-effective model for managing chronic conditions, enhancing patient outcomes through collaborative care.
Pharmaceutical giants like Pfizer and Moderna are profiting immensely from Covid-19 vaccines, with combined profits reaching $65,000 per minute. Despite their financial success, they have largely neglected low-income countries, delivering less than 1% of their vaccine stocks to these regions. The People's Vaccine Alliance highlights the urgent need for equitable vaccine distribution to combat "vaccine apartheid."
The global livestock healthcare market is projected to grow from $50.74 billion in 2023 to $79.39 billion by 2028, with a CAGR of 9.6%. This growth is driven by increasing livestock populations, rising demand for animal products, and the need for effective disease prevention and management strategies. Key players include Merck, Zoetis, and Bayer, with technological advancements enhancing market dynamics.
The global pediatric healthcare app market is projected to grow from $11.90 billion in 2023 to $58.72 billion by 2033, with a CAGR of 17.31%. North America is expected to dominate this market due to its advanced healthcare infrastructure, while Asia-Pacific is anticipated to experience the fastest growth. Key features of these apps include telemedicine, appointment scheduling, and personalized care, enhancing patient convenience and engagement.
Merck will participate in the UBS Global Healthcare Conference on November 13, 2024, featuring Jannie Oosthuizen and Dr. Joerg Koglin in a fireside chat. A live audio webcast will be available for investors, analysts, and the public. Merck, known as MSD outside the U.S. and Canada, focuses on innovative health solutions and has a legacy of over 130 years in developing medicines and vaccines. For more information, visit [Merck's website](http://www.merck.com). The company also issued a forward-looking statement, highlighting potential risks and uncertainties that could affect future results, detailed in their Annual Report and SEC filings available at [SEC's website](http://www.sec.gov).
Merck will participate in the UBS Global Healthcare Conference on November 13, 2024, featuring Jannie Oosthuizen and Dr. Joerg Koglin in a fireside chat. A live audio webcast will be available for investors, analysts, and the public. Merck, known as MSD outside the U.S. and Canada, focuses on innovative health solutions and has a legacy of over 130 years in developing medicines and vaccines.
The global veterinary healthcare market is projected to grow from $192.55 billion in 2023 to $270.68 billion by 2028, with a CAGR of 7.0%. Key growth drivers include rising pet ownership, zoonotic disease prevalence, and advancements in telemedicine and genomic medicine. North America remains the largest market, while major players include Zoetis Inc. and Merck & Co.
Merck & Co., Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Trump appoints RFK Jr. as Health Secretary amid vaccine skepticism
21:34 14.11.2024
merck acquires chinese cancer antibody in deal worth up to 3.3 billion
12:30 14.11.2024
merck invests in new cancer immunotherapy to counter keytruda competition
United States Dollar
LaNova Medicines
Merck & Co., Inc.
Summit Therapeutics plc
Biotheus
Eisai Co., Ltd.
BioNTech SE
Akeso, Inc.
USA
CHN
Umer Raffat
Dean Li
Show more
01:00 14.11.2024
global healthcare services market poised for significant growth through 2028
United States Dollar
Community Health Systems, Inc.
UnitedHealth Group Incorporated
CVS Health Corporation
Regeneron Pharmaceuticals, Inc.
Cardinal Health, Inc.
Fresenius Medical Care AG & Co. KGaA
Centene Corporation
Baxter International Inc.
Mayo Clinic
Agilent Technologies, Inc.
Johnson & Johnson
Pfizer Inc.
Cleveland Clinic Global Solutions LLC
McKesson Corporation
Merck & Co., Inc.
Abbott Laboratories
Bristol-Myers Squibb Company
Quest Diagnostics Incorporated
HCA Healthcare, Inc.
Gilead Sciences, Inc.
Kaiser Permanente Group Trust
Cigna Corporation
Stryker Corporation
Tenet Healthcare Corporation
Danaher Corporation
AbbVie Inc.
Boston Scientific Corporation
Molina Healthcare, Inc.
Align Technology, Inc.
AmerisourceBergen Corporation
Laboratory Corporation OF America Holdings
DaVita Inc.
Eli Lilly and Company
Humana Inc.
West Pharmaceutical Services, Inc.
Fresenius Medical Care AG & Co. KGaA
Kaiser Permanente
UnitedHealth Group Incorporated
Tenet Healthcare
HCA Healthcare
Show more
20:40 11.11.2024
pharmaceutical industry scandals and lobbying influence on public health decisions
United States Dollar
Novartis AG
Merck & Co., Inc.
Moderna, Inc.
GlaxoSmithKline
Pfizer Inc.
Takeda
AbbVie Inc.
Bristol Meyers
Sanofi
Hoffmann-La Roche AG
Johnson & Johnson
USA
Jean-François Delfraissy
Christian Perronne
Arnaud Fontanet
Robert Malone
Didier Raoult
Show more
15:20 11.11.2024
global livestock healthcare market projected to reach 79.39 billion by 2028
Elanco Animal Health Incorporated
Zoetis Inc.
Bayer HealthCare AG
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
CHN
RUS
USA
JPN
BRA
KOR
DEU
GBR
IND
IDN
AUS
Bayer Healthcare AG
The Archer-Daniels-Midland Company
Zoetis Inc.
Merck & Co Inc.
Boehringer Ingelheim International GmbH
Show more
13:00 08.11.2024
asia-pacific leads rapid growth in patient-centric healthcare applications market
United States Dollar
Siemens Healthineers AG
Koninklijke Philips N.V.
Merck & Co., Inc.
Boston Scientific Society
Pfizer Inc.
FRA
CHN
ESP
BRA
KOR
IND
ZAF
ITA
CAN
USA
JPN
MEX
GBR
DEU
ARE
AUS
Show more
00:19 07.11.2024
merck executives to speak at upcoming ub global healthcare conference
12:45 06.11.2024
merck executives to speak at ubS global healthcare conference in november
12:45 06.11.2024
global veterinary healthcare market projected to reach 270 billion by 2028
United States Dollar
Eli Lilly and Company
Ceva Animal Health LLC
Vetoquinol India Animal Health Pvt Ltd
Merck & Co., Inc.
MSD Animal Health UK Ltd.
IDEXX Laboratories, Inc.
Zoetis Inc.
C.H. Boehringer Sohn AG & Co. KG
National Veterinary Associates Inc.
Phirbo Animal Health
Evonik Industries AG
Boehringer Ingelheim GmbH
Patterson Companies, Inc.
Pets at Home Group Plc
CHN
FRA
RUS
JPN
USA
BRA
KOR
DEU
GBR
IND
IDN
AUS
Show more
02:00 05.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Private Equity Deals
Supply Chain Management
Government Economic Policies
Cryptocurrency Trends
Retail and Consumer Goods
Fintech Startups
Workplace Trends
Central Bank Actions
Central Banks and Digital Currencies
Venture Capital Investments
CEO Changes
Finance Mergers & Acquisitions
Energy Sector Developments
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Tencent Holdings Ltd
Google Inc.
NIO Inc.
Nikkei 225
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Tesla, Inc.
MARA Holdings, Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Egyptian Pound
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
South Korean Won
Thai Baht
Mexican Peso
Croatian Kuna
Bahraini Dinar
People: